Phibro Animal Health (PAHC) Competitors $20.97 -0.08 (-0.38%) (As of 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PAHC vs. PTCT, RYTM, MLTX, JANX, MRUS, XENE, EWTX, ZLAB, TWST, and MORShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include PTC Therapeutics (PTCT), Rhythm Pharmaceuticals (RYTM), MoonLake Immunotherapeutics (MLTX), Janux Therapeutics (JANX), Merus (MRUS), Xenon Pharmaceuticals (XENE), Edgewise Therapeutics (EWTX), Zai Lab (ZLAB), Twist Bioscience (TWST), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. PTC Therapeutics Rhythm Pharmaceuticals MoonLake Immunotherapeutics Janux Therapeutics Merus Xenon Pharmaceuticals Edgewise Therapeutics Zai Lab Twist Bioscience MorphoSys Phibro Animal Health (NASDAQ:PAHC) and PTC Therapeutics (NASDAQ:PTCT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership, dividends, valuation and risk. Which has more risk and volatility, PAHC or PTCT? Phibro Animal Health has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, PTC Therapeutics has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Does the MarketBeat Community favor PAHC or PTCT? PTC Therapeutics received 250 more outperform votes than Phibro Animal Health when rated by MarketBeat users. Likewise, 61.85% of users gave PTC Therapeutics an outperform vote while only 59.92% of users gave Phibro Animal Health an outperform vote. CompanyUnderperformOutperformPhibro Animal HealthOutperform Votes31159.92% Underperform Votes20840.08% PTC TherapeuticsOutperform Votes56161.85% Underperform Votes34638.15% Do analysts prefer PAHC or PTCT? Phibro Animal Health presently has a consensus price target of $20.50, suggesting a potential downside of 1.16%. PTC Therapeutics has a consensus price target of $54.08, suggesting a potential upside of 19.38%. Given PTC Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe PTC Therapeutics is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50PTC Therapeutics 3 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.47 Which has preferable earnings & valuation, PAHC or PTCT? Phibro Animal Health has higher revenue and earnings than PTC Therapeutics. PTC Therapeutics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.05B0.80$2.42M$0.4348.23PTC Therapeutics$900.66M3.88-$626.60M-$5.94-7.63 Is PAHC or PTCT more profitable? Phibro Animal Health has a net margin of 1.67% compared to PTC Therapeutics' net margin of -50.32%. Phibro Animal Health's return on equity of 21.59% beat PTC Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health1.67% 21.59% 5.85% PTC Therapeutics -50.32%N/A -16.44% Does the media favor PAHC or PTCT? In the previous week, Phibro Animal Health had 2 more articles in the media than PTC Therapeutics. MarketBeat recorded 3 mentions for Phibro Animal Health and 1 mentions for PTC Therapeutics. Phibro Animal Health's average media sentiment score of 0.75 beat PTC Therapeutics' score of 0.30 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive PTC Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals have more ownership in PAHC or PTCT? 99.3% of Phibro Animal Health shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by insiders. Comparatively, 5.5% of PTC Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryPhibro Animal Health beats PTC Therapeutics on 11 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$840.03M$6.59B$5.16B$8.99BDividend Yield2.22%2.96%4.96%4.20%P/E Ratio48.2310.6787.2417.02Price / Sales0.80195.421,137.12120.43Price / Cash10.7257.1543.2737.84Price / Book3.275.104.814.91Net Income$2.42M$150.98M$120.16M$225.21M7 Day Performance-4.16%1.18%1.17%3.27%1 Month Performance-11.25%-6.44%16.27%1.80%1 Year Performance79.10%6.18%28.43%16.50% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health3.9521 of 5 stars$20.97-0.4%$20.50-2.2%+81.8%$849.35M$1.05B48.771,940Analyst DowngradePTCTPTC Therapeutics3.755 of 5 stars$45.33-2.0%$54.08+19.3%+64.1%$3.50B$900.66M-7.631,410RYTMRhythm Pharmaceuticals3.8688 of 5 stars$56.02-0.2%$66.90+19.4%+20.9%$3.44B$112.53M-12.94140MLTXMoonLake Immunotherapeutics1.2544 of 5 stars$51.95-0.4%$81.43+56.7%-8.3%$3.32BN/A-40.272JANXJanux Therapeutics3.6367 of 5 stars$56.38-0.8%$89.90+59.5%+404.2%$2.96B$13.05M-48.1930Analyst UpgradeInsider TradeShort Interest ↑MRUSMerus2.4894 of 5 stars$42.76+2.2%$85.64+100.3%+53.0%$2.93B$43.95M-10.8337Positive NewsXENEXenon Pharmaceuticals2.4515 of 5 stars$38.31-0.8%$56.00+46.2%-15.7%$2.92B$9.43M-13.59251EWTXEdgewise Therapeutics2.3867 of 5 stars$30.54-0.8%$43.17+41.3%+162.7%$2.89BN/A-20.3660Insider TradeZLABZai Lab2.0721 of 5 stars$26.52-0.7%$55.00+107.4%-2.6%$2.88B$355.75M-9.572,175Gap DownTWSTTwist Bioscience3.339 of 5 stars$48.25+0.6%$51.90+7.6%+30.7%$2.86B$312.97M-13.40990Gap DownMORMorphoSys0.0687 of 5 stars$18.96flat$14.33-24.4%N/A$2.86B$238.28M-5.45730 Related Companies and Tools Related Companies PTCT Competitors RYTM Competitors MLTX Competitors JANX Competitors MRUS Competitors XENE Competitors EWTX Competitors ZLAB Competitors TWST Competitors MOR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PAHC) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
